2020-05-08T18:08:16+00:00

men with prostate cancer are less prone to COVID-19

05/09/2020 Colombia, Entertainment, Health, World

[ad_1]

Those who are under the aforementioned treatment, for prostate cancer, they are less likely to develop COVID-19 and, if infected, the disease is less severe.

This is the main conclusion of a study led by the University of Italian Switzerland, which is published in the Annals of Oncology magazine; its authors suggest that ADT (Androgen Deprivation Therapy) could protect men from coronavirus infection.

The researchers found that of 4,532 men with COVID-19, 9.5% (430) had cancer and 2.6% (118) had prostate cancer, explains the European Medical Society of Oncology in a press release, which notes that those cancer patients had a 1.8 times higher risk of coronavirus infection and developed a more serious illness.

Call.

The scientists also investigated the numbers of men with this type of cancer who take ADT in this same region and counted a total of 5,273: only four of these people developed COVID-19 infection and none died.

Of the 37,161 men with prostate cancer who were not receiving ADT, 114 developed the disease and 18 died.

“This is the first article that suggests a link between tandrogen deprivation erapia and COVID-19 ″, assures Andrea Alimonti, one of the authors of the work.

The researcher explains that for this analysis they collected data from a large population of patients infected with coronavirus and found that those who “are being treated with ADT for prostate cancer are protected, although all cancer patients have a higher risk of COVID-19 infection than those without cancer“

The researchers suggest that even if men did not have prostate cancer, those who are at high risk of developing COVID-19, they could take ADT for a limited period to prevent infectionWhile those who become infected may take ADT to reduce the severity of symptoms.

Coronavirus

Limitations of the study include the fact that cancer patients with COVID-19 may have undergone more tests for the virus than those without cancer, which may explain the higher prevalence of the coronavirus in cancer patients.

The editor-in-chief of the journal where the research is published, Fabrice André, indicates that they decided to publish this study because it provides a basis for evaluating the prospective treatment efficacy in patients infected with COVID-19.

“However, the study does not provide a definitive conclusion on the role of ADT in patients infected with COVID-19, and this class of drugs should not be used for this purpose until prospective trials have confirmed their efficacy.”

That's right, the owner of the brewery, Franz Mast, told Reuters and quoted by Deutsche Welle: u201cWe want to thank the people and we hope that they will also support us when the trade reopens its doors; that they come here, that they recommend us.

This was the invitation from the brewery, located in the state of Hesse (central Germany), that authorized consumers to claim up to 3 beers per person:

The German media reports that the sale of beer in the country, the third largest consumer of the drink in the world, after the Czech Republic and Poland, according to Dinero en Imagen, was seriously affected by the coronavirus, which forced to close the places where it is most consumed, such as bars, restaurants, beer gardens (outdoor places where they sell food and beer) and sporting events, such as soccer.

men with prostate cancer are less prone to COVID-19

Related Articles